In a sample of 100 hospitals, 34 didn’t meet requirements for publishing machine-readable files of their charges while 14 ...

According to the company, effective January 1, 2025, cyclosporine ophthalmic solution 0.1% (Vevye) will be included on key ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access ...